Distinct Pattern of Gray Matter Atrophy in Mild Alzheimer's Disease Impacts on Cognitive Outcomes of Noninvasive Brain Stimulation
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
26401945
DOI
10.3233/jad-150067
PII: JAD150067
Knihovny.cz E-resources
- Keywords
- Alzheimer’s disease, brain atrophy, cognitive functions, noninvasive brain stimulation; source-based morphometry,
- MeSH
- Alzheimer Disease complications MeSH
- Analysis of Variance MeSH
- Cognition Disorders * etiology pathology therapy MeSH
- Humans MeSH
- Cerebral Cortex physiology MeSH
- Neuropsychological Tests MeSH
- Psychiatric Status Rating Scales MeSH
- Gray Matter pathology physiopathology MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Transcranial Magnetic Stimulation methods MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
BACKGROUND: Repetitive transcranial magnetic stimulation (rTMS) is a promising tool to study and modulate brain plasticity. OBJECTIVE: Our aim was to investigate the effects of rTMS on cognitive functions in patients with mild cognitive impairment and Alzheimer's disease (MCI/AD) and assess the effect of gray matter (GM) atrophy on stimulation outcomes. METHODS: Twenty MCI/AD patients participated in the proof-of-concept controlled study. Each patient received three sessions of 10 Hz rTMS of the right inferior frontal gyrus (IFG), the right superior temporal gyrus (STG), and the vertex (VTX, a control stimulation site) in a randomized order. Cognitive functions were tested prior to and immediately after each session. The GM volumetric data of patients were: 1) compared to healthy controls (HC) using source-based morphometry; 2) correlated with rTMS-induced cognitive improvement. RESULTS: The effect of the stimulated site on the difference in cognitive scores was statistically significant for the Word part of the Stroop test (ST-W, p = 0.012, linear mixed models). As compared to the VTX stimulation, patients significantly improved after both IFG and STG stimulation in this cognitive measure. MCI/AD patients had significant GM atrophy in characteristic brain regions as compared to HC (p = 0.029, Bonferroni corrected). The amount of atrophy correlated with the change in ST-W scores after rTMS of the STG. CONCLUSION: rTMS enhanced cognitive functions in MCI/AD patients. We demonstrated for the first time that distinct pattern of GM atrophy in MCI/AD diminishes the cognitive effects induced by rTMS of the temporal neocortex.
References provided by Crossref.org
Physiology-inspired bifocal fronto-parietal tACS for working memory enhancement
Non-invasive stimulation for treating cognitive impairment in Alzheimer disease
Is the vertex a good control stimulation site? Theta burst stimulation in healthy controls
Gray Matter Changes in Parkinson's and Alzheimer's Disease and Relation to Cognition